CXCL1 and Miyoshi myopathy: To test this hypothesis, we used anti-CXCL1 neutralizing antibody (15 μg/ml) in migration assays and show that it abrogates MM transmigration towards HDAC3 KD HS-5 cells (Fig. S5a).